專利授權區國立清華大學國際產學營運總中心 Operations Center for Industry Collaboration

搜尋專利授權區

關鍵字

» 新增關鍵字

選單

專利授權區

專利授權區
專利名稱(中)	治療大腸結直腸癌的藥物組合篩選方法、篩選藥物組合與其應用
專利名稱(英)	METHOD OF SCREENING FOR DRUG COMBINATION FOR COLORECTAL CARCINOMA TREATMENT, DRUG COMBINATION AND USE THEREOF
專利家族	中華民國：202425983(公開號) 大陸：CN 118267465 A(公開號) 美國：US-2024-0207237-A1(公開號)
專利權人	國立清華大學 100.00%
發明人	曾繁根
技術領域	生化醫藥

專利摘要(中)
本發明提供一種治療大腸結直腸癌的藥物組合篩選方法、篩選藥物組合與其應用。所述藥物組合包括選自瑞格非尼（regorafenib）、吉西他濱（gemcitabine）、西妥昔單抗（cetuximab）與5-氟尿嘧啶（5-Fluorouracil，5-FU）中的至少三者。

專利摘要(英)
A method of screening for a drug combination for treating colorectal carcinoma, the screened drug combination and its related application are provided. The drug combination includes at least three selected from Regorafenib, Gemcitabine, Cetuximab and 5-Fluorouracil. With the method of the disclosure, the best and novel drug combination can be selected from the existing clinical drugs, the technical effect of rapidly screening for a drug combination can be achieved, and the screened combination drug has an excellent therapeutic effect.

專利摘要(英)

A method of screening for a drug combination for treating colorectal carcinoma, the screened drug combination and its related application are provided. The drug combination includes at least three selected from Regorafenib, Gemcitabine, Cetuximab and 5-Fluorouracil. With the method of the disclosure, the best and novel drug combination can be selected from the existing clinical drugs, the technical effect of rapidly screening for a drug combination can be achieved, and the screened combination drug has an excellent therapeutic effect.

聯絡資訊
承辦人姓名	楊美茹
承辦人電話	03-5715131 #62305
承辦人Email	mjyang2@mx.nthu.edu.tw